Hannum, M. E. et al. Taste loss as a distinct symptom of COVID-19: A systematic review and meta-analysis. Chem. Senses 47, bja001 (2022).
Hajikhani, B. et al. Olfactory and gustatory dysfunction in COVID-19 patients: A meta-analysis study. Physiol. Rep. 8, e14578 (2020).
Butowt, R. & von Bartheld, C. S. Anosmia in COVID-19: Underlying mechanisms and assessment of an olfactory route to brain infection. Neuroscientist 27, 582–603 (2021).
von Bartheld, C. S., Hagen, M. M. & Butowt, R. Prevalence of chemosensory dysfunction in COVID-19 patients: A systematic review and meta-analysis reveals significant ethnic differences. medRxiv https://doi.org/10.1101/2020.06.15.20132134 (2020).
Iravani, B., Arshamian, A. & Lundström, J. N. Loss of olfactory sensitivity is an early and reliable marker for COVID-19. Chem. Senses 47, 1–7 (2022).
Qiu, C. et al. Olfactory and gustatory dysfunction as an early identifier of COVID-19 in adults and children: An international multicenter study. Otolaryngol. Head Neck Surg. (United States) 163, 714–721 (2020).
Whitcroft, K. L. & Hummel, T. Olfactory dysfunction in COVID-19: Diagnosis and management. JAMA 323, 2512–2514 (2020).
Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271-280.e8 (2020).
Brann, D. H. et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. 6, eabc5801 (2020).
Baxter, B. D. et al. Transcriptional profiling reveals potential involvement of microvillous TRPM5-expressing cells in viral infection of the olfactory epithelium. bioRxiv Prepr. Serv. Biol. https://doi.org/10.1101/2020.05.14.096016 (2020).
Chen, M. et al. Elevated ACE2 expression in the olfactory neuroepithelium: Implications for anosmia and upper respiratory SARS-CoV-2 entry and replication. bioRxiv https://doi.org/10.1101/2020.05.08.084996 (2020).
Heydel, J. M. et al. Odorant-binding proteins and xenobiotic metabolizing enzymes: Implications in olfactory perireceptor events. Anat. Rec. (Hoboken) 296, 1333–1345 (2013).
Villar, P. S., Delgado, R., Vergara, C., Reyes, J. G. & Bacigalupo, J. Energy requirements of odor transduction in the chemosensory cilia of olfactory sensory neurons rely on oxidative phosphorylation and glycolytic processing of extracellular glucose. J. Neurosci. 37, 5736–5743 (2017).
Bryche, B. et al. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain. Behav. Immun. 89, 579 (2020).
Schwob, J. E. Neural regeneration and the peripheral olfactory system. Anat. Rec. 269, 33–49 (2002).
Shelton, J. F. et al. The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. Nat. Genet. 54, 121–124 (2022).
Torabi, A. et al. Proinflammatory cytokines in the olfactory mucosa result inCOVID-19 induced anosmia. ACS Chem. Neurosci. 11, 1909–1913 (2020).
Karamali, K., Elliott, M. & Hopkins, C. COVID-19 related olfactory dysfunction. Curr. Opin. Otolaryngol. Head Neck Surg. 30, 19 (2022).
Najafloo, R. et al. Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments. ACS Chem. Neurosci. 12, 3795–3805 (2021).
Stuck, B. A., Menzel, S., Laudien, M., Hintschich, C. A. & Hummel, T. COVID-19-induced olfactory loss. J. Allergy Clin. Immunol. 151, 895 (2023).
Cantuti-Castelvetri, L. et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370, 856–860 (2020).
Hopkins, C., Lechien, J. R. & Saussez, S. More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival. Med. Hypotheses 146, 110406 (2021).
Finlay, J. B. et al. Persistent post-COVID-19 smell loss is associated with inflammatory infiltration and altered olfactory epithelial gene expression. bioRxiv https://doi.org/10.1101/2022.04.17.488474 (2022).
Ohla, K. et al. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss. Rhinology 60, 207–217 (2022).
Boscolo-Rizzo, P. et al. Self-reported smell and taste recovery in coronavirus disease 2019 patients: A one-year prospective study. Eur. Arch. Otorhinolaryngol. 279, 515–520 (2021).
Vaira, L. A. et al. The effects of persistent olfactory and gustatory dysfunctions on quality of life in long-COVID-19 patients. Life (Basel, Switzerland) 12, 141 (2022).
Tan, B. K. J. et al. Prognosis and persistence of smell and taste dysfunction in patients with covid-19: Meta-analysis with parametric cure modelling of recovery curves. BMJ. 378, (2022).
Ferreli, F. et al. Long-standing gustatory and olfactory dysfunction in COVID-19 patients: A prospective study. Eur. Arch. Otorhinolaryngol. 279, 4633–4640 (2022).
Hintschich, C. A. et al. Persisting olfactory dysfunction in post-COVID-19 is associated with gustatory impairment: Results from chemosensitive testing eight months after the acute infection. PLoS ONE 17, e0265686 (2022).
Soter, A. et al. Accuracy of self-report in detecting taste dysfunction. Laryngoscope 118, 611–617 (2008).
Nørgaard, H. J. & Fjaeldstad, A. W. Differences in correlation between subjective and measured olfactory and gustatory dysfunctions after initial ear, nose and throat evaluation. Int. Arch. Otorhinolaryngol. 25, E563–E569 (2021).
Lechien, J. R. et al. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients. Head Neck 42, 1583–1590 (2020).
Vaira, L. A. et al. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study. Head Neck 42, 1560 (2020).
Mazzatenta, A. et al. Smell and taste in severe CoViD-19: Self-reported vs. testing. Front. Med. 7, 589409 (2020).
Hopkins, C., Surda, P., Whitehead, E. & Kumar, B. N. Early recovery following new onset anosmia during the COVID-19 pandemic—An observational cohort study. J. Otolaryngol. Head Neck Surg. 49, 1–6 (2020).
Doležal, P. et al. Results of treatment of olfactory disorders after COVID-19 disease using olfactory training. Otorinolaryngol. Foniatr. 71, 147–155 (2022).
Topal, K., Atalay, F. & Kars, A. Cacosmia and cacogeusia in patients with persistent anosmia and ageusia due to COVID-19. Eur. J. Rhinol. Allergy 4, 87–90 (2021).
Printza, A. & Constantinidis, J. The role of self-reported smell and taste disorders in suspected COVID-19. Eur. Arch. Otorhinolaryngol. 277, 2625–2630 (2020).
Ahmed, M. M. et al. Gender difference in perceived symptoms and laboratory investigationsin suspected and confirmed COVID-19 cases: A retrospective study. J. Prim. Care Community Health 12, 215013272110397 (2021).
Whitaker, M. et al. Variant-specific symptoms of COVID-19 among 1,542,510 people in England. medRxiv https://doi.org/10.1101/2022.05.21.22275368 (2022).
Menni, C. et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: A prospective observational study from the ZOE COVID Study. Lancet 399, 1618–1624 (2022).
Brejová, B. et al. Sequencing SARS-CoV-2 in Slovakia: An unofficial genomic surveillance report. medRxiv https://doi.org/10.1101/2021.07.13.21260431 (2021).
Stadtmüller, M. et al. Emergence and spread of a sub-lineage of SARS-CoV-2 Alpha variant B.1.1.7. in Europe, and with further evolution of spike mutation accumulations shared with the Beta and Gamma variants. Virus Evol. 8, veac010 (2022).
Vaira, L. A. et al. Smell and taste recovery in coronavirus disease 2019 patients: A 60-day objective and prospective study. J. Laryngol. Otol. 134, 703–709 (2020).
Otte, M. S., Eckel, H. N. C., Poluschkin, L., Klussmann, J. P. & Luers, J. C. Olfactory dysfunction in patients after recovering from COVID-19. Acta Otolaryngol. 140, 1032–1035 (2020).
Huart, C. et al. Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: An international view. Int. Forum Allergy Rhinol. 11, 1041–1046 (2021).
Vodička, J., Pellant, A. & Chrobok, V. Screening of olfactory function using odourized markers. Rhinology 45, 164–168 (2007).
Vodička, J. et al. Normative data of subjective olfactory tests for the Czech population. Otorhinolaryngol. Phoniatr. 3, 119–124 (2011).
Brothánková, P., Vodička, J. & Pospíchalová, K. Test–retest assessment of the olfactory test reliability (Odorized Markers Test). Ces. a Slov. Neurol. a Neurochir. 85, 44–48 (2022).
Pospichalova, K., Vodicka, J. & Kopal, A. New test of odor pleasantness in Parkinson’s disease. Funct. Neurol. 31, 149 (2016).
Fernández-De-las-peñas, C. et al. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: The LONG-COVID-EXP-CM multicenter study. J. Clin. Med. 11, 413 (2022).
Doty, R. L., Smith, R., Mckeown, D. A. & Raj, J. Tests of human olfactory function: Principal components analysis suggests that most measure a common source of variance. Percept. Psychophys. 56, 701–707 (1994).
Moein, S. T. et al. Smell dysfunction: A biomarker for COVID-19. Int. Forum Allergy Rhinol. 10, 944–950 (2020).
Lechien, J. R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur. Arch. Otorhinolaryngol. 277, 2251–2261 (2020).
Beltrán-Corbellini, et al. Acute-onset smell and taste disorders in the context of COVID-19: A pilot multicentre polymerase chain reaction based case-control study. Eur. J. Neurol. 27, 1738–1741 (2020).
Gerkin, R. C. et al. Recent smell loss is the best predictor of COVID-19 among individuals with recent respiratory symptoms. Chem. Senses 46, bjaa081 (2021).
Parma, V. et al. More than smell—COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. Chem. Senses 45, 609–622 (2020).
Stafford, L. D. & Whittle, A. Obese individuals have higher preference and sensitivity to odor of chocolate. Chem. Senses 40, 279–284 (2015).
Peng, M., Coutts, D., Wang, T. & Cakmak, Y. O. Systematic review of olfactory shifts related to obesity. Obes. Rev. 20, 325–338 (2019).
Lerner, D. K. et al. Clinical features of parosmia associated with COVID-19 infection. Laryngoscope 132, 633 (2022).
Hummel, T. & Lötsch, J. Prognostic factors of olfactory dysfunction. Arch. Otolaryngol. Head. Neck Surg. 136, 347–351 (2010).
Klopfenstein, T. et al. Third of patients have gustatory dysfunction 9 months after SARS-CoV-2 infection: The ANOSVID study. Int. J. Infect. Dis. 119, 114–116 (2022).
Xu, H. et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 12, 1–5 (2020).
Sato, T. et al. Expression of ACE2 and TMPRSS2 proteins in the upper and lower aerodigestive tracts of rats. bioRxiv https://doi.org/10.1101/2020.05.14.097204 (2020).
Cooper, K. W. et al. COVID-19 and the chemical senses: Supporting players take center stage. Neuron 107, 219–233 (2020).
Singer-Cornelius, T., Cornelius, J., Oberle, M., Metternich, F. U. & Brockmeier, S. J. Objective gustatory and olfactory dysfunction in COVID-19 patients: A prospective cross-sectional study. Eur. Arch. Otorhinolaryngol. 278, 3325–3332 (2021).